Patents by Inventor Jill Uyeno
Jill Uyeno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8052718Abstract: A non-invasive blood vessel occlusion device includes a pair of pressure-applying members with opposed tissue-contacting surfaces, a supporting shaft configured to adjust the distance between tissue-contacting surfaces, and at least one sensor for locating a blood vessel disposed on at least one pressure-applying member. Blood vessels may be occluded by indirectly compressing the artery by compressing tissue near to an artery. The occlusion device finds use in, for example, treating uterine disorders and conditions which may be treated by occlusion of the uterine arteries. A uterine artery may be accessed via a body cavity, such as a patient's vagina, and may be occluded by compressing a portion of the vaginal wall around a portion of a uterine artery.Type: GrantFiled: November 19, 2002Date of Patent: November 8, 2011Assignee: Vascular Control Systems, Inc.Inventors: Fred H. Burbank, Michael L. Jones, R. J. Serra, Greig E. Altieri, Jill Uyeno, Yu-Tung Wong, Randy Werneth
-
Patent number: 7651511Abstract: The invention provides devices, systems and methods for clamping arteries which are useful in reducing or abolishing blood flow in an artery, and may be used to control hemorrhage following a caesarian delivery. A clamping device embodying features of the invention includes a pair of clamping members with opposed pressure-applying members having facing pressure-applying surfaces, at least one of which is a yieldable pressure-applying surface. The yieldable pressure-applying surface is preferably resilient. The clamping members are configured to adjust the distance between pressure-applying surfaces, and a blood flow sensor is disposed on at least one of the pressure-applying members to aid in locating the target artery and also to monitor blood flow through the artery. The clamping device is particularly suitable for occluding uterine arteries by compressing the broad ligament which contains the uterine artery and which is connected to the patient's uterus with the arterial clamp.Type: GrantFiled: February 5, 2003Date of Patent: January 26, 2010Assignee: Vascular Control Systems, Inc.Inventors: Fred H. Burbank, Michael L. Jones, R. J. Serra, Greig E. Altieri, Jill Uyeno
-
Patent number: 7616979Abstract: The invention provides a devices, methods and systems to measure and record uterine tissue environment components such as pH during the course of uterine artery occlusion. The uterus becomes ischemic due to the occlusion thereof, and its pH drops sharply within minutes of uterine artery occlusion and remains relatively low for a period of time. The return of normal pH is an indicator of return of blood to the ischemic tissue. In use, a catheter with a pH measuring tip is advanced through the patient's vaginal canal and into the patient's uterine cavity until the pH measuring active electrode on the distal end of the catheter contacts or penetrates the uterine fundus. The active electrode detects the pH and a signal representing pH is transmitted to a pH recording and monitoring device which preferably displays the pH. The signal may be transmitted through a conductor or by a radio transmitter. Components other than pH may be monitored such a pCO2, and pO2.Type: GrantFiled: April 28, 2006Date of Patent: November 10, 2009Assignee: Vascular Control Systems, Inc.Inventors: Michael L. Jones, Jill Uyeno, Fred H. Burbank, Greig E. Altieri
-
Patent number: 7404821Abstract: The invention is directed to instruments and procedures using such instruments for temporarily reducing or terminating blood flow through a female patient's uterine artery to treat post partum hemorrhage (PPH). The uterine artery is occluded by a clamping device which includes a pair of pivotally connected clamping members, with each of the clamping members having a handle and a clamping element at the distal end of the handle. The clamping elements are inclined with respect to the longitudinal axes of the handles at an included obtuse angle between about 120° and about 170°, preferably between about 130° and 160°. An artery locating sensor is provided on the distal end of at least one of the clamping elements. Preferably, the artery locating sensor is a Doppler ultrasound blood flow sensor.Type: GrantFiled: January 30, 2003Date of Patent: July 29, 2008Assignee: Vascular Control Systems, Inc.Inventors: Fred H. Burbank, Michael L. Jones, Jill Uyeno
-
Publication number: 20080097473Abstract: The invention is directed to instruments and procedures using such instruments for temporarily reducing or terminating blood flow through a female patient's uterine artery to treat post partum hemorrhage (PPH). The uterine artery is occluded by a clamping device which includes a pair of pivotally connected clamping members, with each of the clamping members having a handle and a clamping element at the distal end of the handle. The clamping elements are inclined with respect to the longitudinal axes of the handles at an included obtuse angle between about 120° and about 170°, preferably between about 130° and 160°. An artery locating sensor is provided on the distal end of at least one of the clamping elements. Preferably, the artery locating sensor is a Doppler ultrasound blood flow sensor.Type: ApplicationFiled: July 30, 2007Publication date: April 24, 2008Inventors: Fred Burbank, Michael Jones, Jill Uyeno
-
Patent number: 7333844Abstract: The invention provides a devices, methods and systems to measure and record uterine tissue environment components such as pH during the course of uterine artery occlusion. The uterus becomes ischemic due to the occlusion thereof, and its pH drops sharply within minutes of uterine artery occlusion and remains relatively low for a period of time. The return of normal pH is an indicator of return of blood to the ischemic tissue. In use, a catheter with a pH measuring tip is advanced through the patient's vaginal canal and into the patient's uterine cavity until the pH measuring active electrode on the distal end of the catheter contacts or penetrates the uterine fundus. The active electrode detects the pH and a signal representing pH is transmitted to a pH recording and monitoring device which preferably displays the pH. The signal may be transmitted through a conductor or by a radio transmitter. Components other than pH may be monitored such a pCO2, and pO2.Type: GrantFiled: March 28, 2003Date of Patent: February 19, 2008Assignee: Vascular Control Systems, Inc.Inventors: Michael L. Jones, Jill Uyeno, Fred H. Burbank, Greig E. Altieri
-
Patent number: 7229465Abstract: The invention provides devices, systems and methods for occluding arteries without puncturing skin or vessel walls. The devices, systems and methods for occluding arteries are configured to be applied to arteries externally of the arteries. Occlusion may be temporary or permanent, and may be partial or complete. Clamping a device to tissue near to an artery is effective to compress tissue around the artery and to indirectly compress the artery. The methods, devices and systems of the invention find use in, for example, treatment of uterine disorders and conditions which may be treated by occlusion of the uterine arteries. A uterine artery may be accessed via a patient's vagina by compressing a portion of the vaginal wall around a portion of a uterine artery to occlude a uterine artery. Clamping of an artery may also be performed by clamping a device directly onto an artery.Type: GrantFiled: March 28, 2002Date of Patent: June 12, 2007Assignee: Vascular Control Systems, Inc.Inventors: Fred H. Burbank, Michael L. Jones, R. J. Serra, Greig Altieri, Jill Uyeno, Yu-Tung Wong, Randy Werneth
-
Publication number: 20070049973Abstract: The invention provides devices, systems and methods for reducing or abolishing blood flow by occluding uterine arteries for treating adenomyosis and endometriosis. A non-invasive uterine artery occlusion device embodying features of the invention includes a pair of pressure-applying members with opposed tissue-contacting surfaces, a supporting shaft configured to adjust the distance between tissue-contacting surfaces, and at least one sensor for locating a uterine artery disposed on at least one pressure-applying member. Uterine arteries are occluded by indirectly compressing the artery by compressing tissue near to an artery. One uterine artery may be occluded or both may be occluded simultaneously. A uterine artery may be accessed via a body cavity, such as a patient's vagina, and may be occluded by compressing a portion of the vaginal wall around a portion of a uterine artery.Type: ApplicationFiled: August 29, 2005Publication date: March 1, 2007Inventors: Fred Burbank, Michael Jones, R. Serra, Greig Altieri, Jill Uyeno, Yu-Tung Wong, Randy Werneth
-
Patent number: 7141057Abstract: Exemplary embodiments are directed to providing a method of preparing an anatomical vessel contained within a tissue bundle for ligation, including positioning a cannula adjacent to the tissue bundle, wherein the positioning is non-penetrating, the cannula including a first extendable member, a second extendable member, a Doppler wand, and a distal end, transmitting ultrasound signals toward the vessel through the tissue bundle with the Doppler wand, receiving ultrasound signals reflected by the vessel through the tissue bundle with the Doppler wand, invaginating the tissue bundle with the first extendable member on a first side of the tissue bundle, invaginating the tissue bundle with the second extendable member on a second side of the bundle opposite the first side, and interpenetrating a length of ligation material between the first and second extendable members on a side of the vessel opposite the cannula distal end.Type: GrantFiled: September 18, 2003Date of Patent: November 28, 2006Assignee: Vascular Control Systems, Inc.Inventors: Fred Burbank, Michael L. Jones, Jill Uyeno, Greig E. Altieri, R. J. Serra
-
Publication number: 20060241337Abstract: The invention provides a devices, methods and systems to measure and record uterine tissue environment components such as pH during the course of uterine artery occlusion. The uterus becomes ischemic due to the occlusion thereof, and its pH drops sharply within minutes of uterine artery occlusion and remains relatively low for a period of time. The return of normal pH is an indicator of return of blood to the ischemic tissue. In use, a catheter with a pH measuring tip is advanced through the patient's vaginal canal and into the patient's uterine cavity until the pH measuring active electrode on the distal end of the catheter contacts or penetrates the uterine fundus. The active electrode detects the pH and a signal representing pH is transmitted to a pH recording and monitoring device which preferably displays the pH. The signal may be transmitted through a conductor or by a radio transmitter. Components other than pH may be monitored such a pCO2, and pO2.Type: ApplicationFiled: April 28, 2006Publication date: October 26, 2006Inventors: Michael Jones, Jill Uyeno, Fred Burbank, Greig Altieri
-
Publication number: 20060015144Abstract: The invention is directed to an intravaginal staple for occluding a female patient's uterine artery in the treatment of a uterine disorder such as fibroids, DUB, PPH, uterine bleeding after caesarian delivery and the like. The intravaginal staple includes an occluding bar having a pressure applying surface and at least one and preferably two tissue penetrating legs which are provided with protuberances which help to retain the staple leg within the penetrated tissue. At least part of the staple is preferably formed of bioabsorbable material so that it will in part self destruct at a preselected time period by separation of staple components caused by the bioabsorption of a bioabsorbable portion of the staple. The staple deployment system may be provided with elongated handles and staple deploying mechanisms on the distal ends of the handles to drive the legs of the staple into the tissue bundle about the uterine artery so that pressure applied by the occlusion bar occludes the uterine artery.Type: ApplicationFiled: July 19, 2004Publication date: January 19, 2006Inventors: Fred Burbank, Michael Jones, Greig Altieri, Jill Uyeno
-
Publication number: 20050101974Abstract: The invention provides devices, systems and methods for clamping arteries which are useful in reducing or abolishing blood flow in an artery, and may be used to control hemorrhage following a caesarian delivery. A clamping device embodying features of the invention includes a pair of clamping members with opposed pressure-applying members having facing pressure-applying surfaces, at least one of which is a yieldable pressure-applying surface. The yieldable pressure-applying surface is preferably resilient. The clamping members are configured to adjust the distance between pressure-applying surfaces, and a blood flow sensor is disposed on at least one of the pressure-applying members to aid in locating the target artery and also to monitor blood flow through the artery. The clamping device is particularly suitable for occluding uterine arteries by compressing the broad ligament which contains the uterine artery and which is connected to the patient's uterus with the arterial clamp.Type: ApplicationFiled: February 5, 2003Publication date: May 12, 2005Inventors: Fred Burbank, Michael Jones, R. Serra, Greig Altieri, Jill Uyeno
-
Publication number: 20040193028Abstract: The invention provides a devices, methods and systems to measure and record uterine tissue environment components such as pH during the course of uterine artery occlusion. The uterus becomes ischemic due to the occlusion thereof, and its pH drops sharply within minutes of uterine artery occlusion and remains relatively low for a period of time. The return of normal pH is an indicator of return of blood to the ischemic tissue. In use, a catheter with a pH measuring tip is advanced through the patient's vaginal canal and into the patient's uterine cavity until the pH measuring active electrode on the distal end of the catheter contacts or penetrates the uterine fundus. The active electrode detects the pH and a signal representing pH is transmitted to a pH recording and monitoring device which preferably displays the pH. The signal may be transmitted through a conductor or by a radio transmitter. Components other than pH may be monitored such a pCO2, and pO2.Type: ApplicationFiled: March 28, 2003Publication date: September 30, 2004Applicant: Vascular Control Systems, Inc.Inventors: Michael L. Jones, Jill Uyeno, Fred H. Burbank, Greig E. Altieri
-
Publication number: 20040153097Abstract: The invention is directed to instruments and procedures using such instruments for temporarily reducing or terminating blood flow through a female patient's uterine artery to treat post partum hemorrhage (PPH). The uterine artery is occluded by a clamping device which includes a pair of pivotally connected clamping members, with each of the clamping members having a handle and a clamping element at the distal end of the handle. The clamping elements are inclined with respect to the longitudinal axes of the handles at an included obtuse angle between about 120° and about 170°, preferably between about 130° and 160°. An artery locating sensor is provided on the distal end of at least one of the clamping elements. Preferably, the artery locating sensor is a Doppler ultrasound blood flow sensor.Type: ApplicationFiled: January 30, 2003Publication date: August 5, 2004Applicant: Vascular Control Systems, Inc.Inventors: Fred H. Burbank, Michael L. Jones, Jill Uyeno
-
Publication number: 20040059352Abstract: Exemplary embodiments are directed to providing a method of preparing an anatomical vessel contained within a tissue bundle for ligation, including positioning a cannula adjacent to the tissue bundle, wherein the positioning is non-penetrating, the cannula including a first extendable member, a second extendable member, a Doppler wand, and a distal end, transmitting ultrasound signals toward the vessel through the tissue bundle with the Doppler wand, receiving ultrasound signals reflected by the vessel through the tissue bundle with the Doppler wand, invaginating the tissue bundle with the first extendable member on a first side of the tissue bundle, invaginating the tissue bundle with the second extendable member on a second side of the bundle opposite the first side, and interpenetrating a length of ligation material between the first and second extendable members on a side of the vessel opposite the cannula distal end.Type: ApplicationFiled: September 18, 2003Publication date: March 25, 2004Applicant: Vascular Control Systems, Inc.Inventors: Fred Burbank, Michael L. Jones, Jill Uyeno, Greig E. Altieri, R. J. Serra
-
Patent number: 6638286Abstract: A ligation device includes a cannula having first and second extendable members and a Doppler wand. The Doppler wand permits an anatomical vessel, such as a blood vessel, to be located in close proximity to the distal end of the cannula. The extendable members are extendable on two opposite sides of the vessel. A length of ligation material, such as suture material, extends through the first extendable member, and is attached to a detachable element mounted to the distalmost end of the extendable member. The second extendable member includes a snare. The first extendable member includes curved portions which, when the member is extended distally, extend the detachable element into position for the snare so that the snare can grab the loop. Once ensnared, the detachable element is released from the first extendable member, which pulls the ligation material around the vessel. The ligation device does not require prior visualization or dissection of the area around the vessel.Type: GrantFiled: November 16, 2000Date of Patent: October 28, 2003Assignee: Vascular Control Systems, Inc.Inventors: Fred Burbank, Michael L. Jones, Jill Uyeno, Greig E. Altieri, R. J. Serra
-
Patent number: 6635065Abstract: Exemplary embodiments are directed to providing a method of preparing an anatomical vessel contained within a tissue bundle for ligation, including positioning a cannula adjacent to the tissue bundle, wherein the positioning is non-penetrating, the cannula including a first extendable member, a second extendable member, a Doppler wand, and a distal end, transmitting ultrasound signals toward the vessel through the tissue bundle with the Doppler wand, receiving ultrasound signals reflected by the vessel through the tissue bundle with the Doppler wand, invaginating the tissue bundle with the first extendable member on a first side of the tissue bundle, invaginating the tissue bundle with the second extendable member on a second side of the bundle opposite the first side, and interpenetrating a length of ligation material between the first and second extendable members on a side of the vessel opposite the cannula distal end.Type: GrantFiled: July 17, 2001Date of Patent: October 21, 2003Assignee: Vascular Control Systems, Inc.Inventors: Fred Burbank, Michael L. Jones, Jill Uyeno, Greig E. Altieri, R. J. Serra
-
Publication number: 20030120306Abstract: The invention provides devices, systems and methods for reducing or abolishing blood flow by occluding arteries. A non-invasive blood vessel occlusion device embodying features of the invention includes a pair of pressure-applying members with opposed tissue-contacting surfaces, a supporting shaft configured to adjust the distance between tissue-contacting surfaces, and at least one sensor for locating a blood vessel disposed on at least one pressure-applying member. Blood vessels may be occluded by indirectly compressing the artery by compressing tissue near to an artery. The invention finds use in, for example, treating uterine disorders and conditions which may be treated by occlusion of the uterine arteries. A uterine artery may be accessed via a body cavity, such as a patient's vagina, and may be occluded by compressing a portion of the vaginal wall around a portion of a uterine artery.Type: ApplicationFiled: November 19, 2002Publication date: June 26, 2003Applicant: Vascular Control SystemInventors: Fred H. Burbank, Michael L. Jones, R. J. Serra, Greig E. Altieri, Jill Uyeno, Yu-Tung Wong, Randy Werneth
-
Publication number: 20030120286Abstract: Medical devices, systems and methods for applying a luminal clip to occlude a body lumen, such as a blood vessel, duct, or lymph node are provided. Devices embodying features of the invention include an elongated pressure-applying member having a handle portion and a jaw portion with a clip-receiving surface; a sensor disposed on a jaw portion; and an energy transmission element connected to the sensor. The sensor may detect and/or locate a body lumen, and may be used to differentiate between a blood vessel and other body lumens. The device can apply a luminal clip to a body lumen to compress and to occlude the lumen. Occlusion may be partial or complete, and may be temporary or permanent. Occlusion of the uterine arteries may treat uterine fibroids, dysfunctional uterine bleeding, and other uterine disorders and conditions; clips may also be applied in cholecystectomy procedures, and in other medical procedures.Type: ApplicationFiled: November 19, 2002Publication date: June 26, 2003Applicant: Vascular Control SystemInventors: Fred H. Burbank, Michael L. Jones, R. J. Serra, Greig E. Altieri, Jill Uyeno, Yu-Tung Wong, Randy Werneth
-
Patent number: 6519485Abstract: A system for assessing organ function couples light emitters into an optical fiber delivery assembly of which the tip extends to or into an internal organ and illuminates tissue; the device senses temperature at the tip, and a collection fiber collects light scattered, reflected or emitted by the surrounding tissue. Control and processing modules drive the laser diodes and process return spectral signals, e.g., to assess metabolic activity and detect onset of shock. A prototype uses four laser diodes with peaks at 735, 760, 805 and 890 nm, with a front end splitter providing a reference beam to a photo detector for normalizing detection output and correcting the signal samples. The device may include a plurality of laser diodes and may select subsets of the sources to tailor spectral illumination to different target enzymes, metabolites or other compounds.Type: GrantFiled: December 13, 2000Date of Patent: February 11, 2003Assignee: The General Hospital CorporationInventors: William P. Wiesmann, Adrian Richard Urias, Jill Uyeno, Adrian Prokop, Jason Milne, Kristopher Jarka, Farbod Ghassemi